TR200100240T2 - Anksiyete bozukluklarının tedavisi - Google Patents

Anksiyete bozukluklarının tedavisi

Info

Publication number
TR200100240T2
TR200100240T2 TR2001/00240T TR200100240T TR200100240T2 TR 200100240 T2 TR200100240 T2 TR 200100240T2 TR 2001/00240 T TR2001/00240 T TR 2001/00240T TR 200100240 T TR200100240 T TR 200100240T TR 200100240 T2 TR200100240 T2 TR 200100240T2
Authority
TR
Turkey
Prior art keywords
treatment
anxiety disorders
serotonin
mammal
administration
Prior art date
Application number
TR2001/00240T
Other languages
English (en)
Inventor
Alan Phebus Lee
Joy Sajdyk Tammy
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200100240T2 publication Critical patent/TR200100240T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Bu bulus anksiyete bozukluklarinin tedavisi veya önlenmesi için,böyle bir tedaviye ihtiyaç duyan bir memeliye bir serotonin 5-HTIF reseptör antagonisti verilmesine dayanan bir yöntem sunmaktadir.
TR2001/00240T 1998-07-27 1999-07-08 Anksiyete bozukluklarının tedavisi TR200100240T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9431098P 1998-07-27 1998-07-27

Publications (1)

Publication Number Publication Date
TR200100240T2 true TR200100240T2 (tr) 2002-01-21

Family

ID=22244420

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00240T TR200100240T2 (tr) 1998-07-27 1999-07-08 Anksiyete bozukluklarının tedavisi

Country Status (14)

Country Link
EP (1) EP0976747A3 (tr)
JP (1) JP2003527305A (tr)
KR (1) KR20010072064A (tr)
CN (1) CN1315830A (tr)
AU (1) AU4977899A (tr)
BR (1) BR9913348A (tr)
CA (1) CA2338740A1 (tr)
EA (1) EA200100182A1 (tr)
HU (1) HUP0102886A3 (tr)
IL (1) IL140540A0 (tr)
NO (1) NO20010390L (tr)
PL (1) PL366197A1 (tr)
TR (1) TR200100240T2 (tr)
WO (1) WO2000006082A2 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60026581T2 (de) 1999-12-20 2006-12-28 Eli Lilly And Co., Indianapolis Indolderivate zur behandlung von depression und angstzuständen
ATE266660T1 (de) * 1999-12-20 2004-05-15 Lilly Co Eli Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten
WO2001046177A1 (en) 1999-12-20 2001-06-28 Eli Lilly And Company Benzofuran derivatives
WO2006088963A1 (en) * 2005-02-17 2006-08-24 Bayer Cropscience Ag Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans
WO2006089024A1 (en) * 2005-02-17 2006-08-24 Bayer Cropscience Ag Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans
EP1863783A4 (en) * 2005-03-23 2008-06-18 Bayer Cropscience Ag IMPROVED PROCESS FOR THE PREPARATION OF INSECTICIDAL PHENYL ALKYL SUBSTITUTED DIHYDROBENZOFURANES
CN107973766B (zh) * 2016-10-21 2020-06-19 石家庄诚志永华显示材料有限公司 含有环烷基的氧芴衍生物的液晶化合物及其应用
TWI744458B (zh) * 2017-02-27 2021-11-01 日商捷恩智股份有限公司 具有二苯并呋喃環的化合物、液晶組成物及液晶顯示元件

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists

Also Published As

Publication number Publication date
HUP0102886A2 (en) 2002-06-29
KR20010072064A (ko) 2001-07-31
NO20010390D0 (no) 2001-01-23
WO2000006082A3 (en) 2000-05-04
JP2003527305A (ja) 2003-09-16
CA2338740A1 (en) 2000-02-10
EP0976747A3 (en) 2000-09-13
PL366197A1 (en) 2005-01-24
AU4977899A (en) 2000-02-21
CN1315830A (zh) 2001-10-03
HUP0102886A3 (en) 2002-12-28
EA200100182A1 (ru) 2001-08-27
WO2000006082A2 (en) 2000-02-10
NO20010390L (no) 2001-03-13
IL140540A0 (en) 2002-02-10
EP0976747A2 (en) 2000-02-02
BR9913348A (pt) 2001-06-12

Similar Documents

Publication Publication Date Title
DE69732868D1 (de) Mittel gegen Juckreiz
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
NO20010446L (no) Substituert anilidforbindelser og metoder
DE69929235D1 (de) Spiro-indole als y5-rezeptor antagonisten
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
CO4290416A1 (es) Antagonistas de receptores de taquicinas no-peptidos
PT1187918E (pt) Antagonistas de tek
TR199801255T2 (tr) Vitronektin reseptör antagonistleri.
WO2000006085A3 (en) Compounds and methods
ATE353875T1 (de) Indolderivate
NO994850L (no) Farmakologiske midler
PT1149078E (pt) Ligandos receptores de 5-ht6 selectivos
DK1176963T3 (da) Anvendelse af dopamin-D3-receptorantagonister til fremstilling af lægemidler til behandling af nyrefunktionsforstyrrelser
DK1480627T3 (da) Fremgangsmåder til mindskelse af angiogenese
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
TR200103123T2 (tr) Monofluoroalkil türevleri.
TR200100240T2 (tr) Anksiyete bozukluklarının tedavisi
DE60025639D1 (de) Substituierte diazepan
TR200002072T2 (tr) Spiropiperidin türevleri
ATE411341T1 (de) Einen nmda rezeptor enthaltende multiprotein- komplexe und deren verwendung
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE69733148D1 (de) Die verwendung von nk-1 rezeptor antagonisten für die behandlung von kognitiven störungen
BR9909878A (pt) 10-canfosulfonato de paroxetina para tratamento de distúrbios do sistema nervoso central
HUP0101350A2 (hu) Generalizált szorongásos rendellenesség kezelése paroxetinnel
IS4686A (is) 5-HT3 viðtaka mótefni fyrir hreyfibilun